- Report
- October 2025
- 188 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- September 2025
- 137 Pages
Global
From €2280EUR$2,549USD£2,006GBP
€2682EUR$2,999USD£2,360GBP
- Report
- October 2025
- 100 Pages
Global
From €3500EUR$4,192USD£3,186GBP
- Report
- September 2023
- 120 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- January 2024
- 200 Pages
Global
From €3712EUR$4,150USD£3,265GBP
- Report
- April 2023
- 117 Pages
Global
From €4249EUR$4,750USD£3,737GBP
- Report
- January 2024
- 182 Pages
Global
From €4025EUR$4,500USD£3,541GBP
- Report
- June 2024
- 149 Pages
Global
From €2236EUR$2,500USD£1,967GBP
The Hyaluronic Acid Raw Material market is an important component of the Immune Disorders Drugs industry. Hyaluronic Acid is a naturally occurring polysaccharide found in the human body, and is used in a variety of medical treatments. It is used to treat a range of immune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. It is also used to treat joint pain, inflammation, and other musculoskeletal conditions. Hyaluronic Acid is also used in cosmetic treatments, such as dermal fillers and skin rejuvenation.
The Hyaluronic Acid Raw Material market is highly competitive, with a number of companies offering products for a variety of applications. Companies in the market include Fidia Farmaceutici, Anika Therapeutics, Seikagaku Corporation, and Ferring Pharmaceuticals. Show Less Read more
